These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1283 related articles for article (PubMed ID: 23387478)

  • 21. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
    Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA
    Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
    Qu Q; Ma X; Zhao Y
    Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
    Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
    J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous silica nanoparticles in biomedical applications.
    Li Z; Barnes JC; Bosoy A; Stoddart JF; Zink JI
    Chem Soc Rev; 2012 Apr; 41(7):2590-605. PubMed ID: 22216418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of lignin-derived dimer and eugenol-functionalized silica nanoparticles with supported lipid bilayers.
    Moradipour M; Chase EK; Khan MA; Asare SO; Lynn BC; Rankin SE; Knutson BL
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111028. PubMed ID: 32305621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
    Lungare S; Hallam K; Badhan RK
    Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer.
    Bellapu KK; Joga R; Kannan BR; Yerram S; Varpe P; Mergu T; Vasu PY; Srivastava S; Kumar S
    Pharm Pat Anal; 2023 Nov; 12(6):261-273. PubMed ID: 38214201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncovalent Surface Locking of Mesoporous Silica Nanoparticles for Exceptionally High Hydrophobic Drug Loading and Enhanced Colloidal Stability.
    Palanikumar L; Kim HY; Oh JY; Thomas AP; Choi ES; Jeena MT; Joo SH; Ryu JH
    Biomacromolecules; 2015 Sep; 16(9):2701-14. PubMed ID: 26200587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps.
    Möller K; Müller K; Engelke H; Bräuchle C; Wagner E; Bein T
    Nanoscale; 2016 Feb; 8(7):4007-19. PubMed ID: 26819069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
    Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
    J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of Mesoporous Silica Nanoparticle Interaction with Hairy Root Cultures during Nanoharvesting of Biomolecules.
    Khan MA; Fugate M; Rogers DT; Sambi J; Littleton JM; Rankin SE; Knutson BL
    Adv Biol (Weinh); 2021 Mar; 5(3):e2000173. PubMed ID: 33729698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems.
    Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered pH-Responsive Mesoporous Carbon Nanoparticles for Drug Delivery.
    Gisbert-Garzarán M; Berkmann JC; Giasafaki D; Lozano D; Spyrou K; Manzano M; Steriotis T; Duda GN; Schmidt-Bleek K; Charalambopoulou G; Vallet-Regí M
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14946-14957. PubMed ID: 32141284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.